| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 519.2K | $12.39M | - | |
| CFO | 226.6K | $5.41M | - | |
| Other | 167.0K | $3.99M | - | |
| Other | 133.2K | $3.18M | - | |
| Other | 108.9K | $2.60M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jan 28, 2020 | Jeremy P. Springhorn46 | Director | Sell | 807 | $62.19 | $50,190.36 | -11.8% | |
| Jan 28, 2020 | Sander van Deventer | EVP, Research & Product Dev. | Sell | 2,227 | $61.61 | $137,214.38 | -4.9% | |
| Jan 28, 2020 | Alexander Edward Kuta III81 | Executive VP, Operations | Sell | 1,478 | $62.14 | $91,848.07 | -3.6% | |
| Jan 28, 2020 | Robert Gut62 | Chief Medical Officer | Sell | 7,493 | $60.18 | $450,954.21 | -21.2% | |
| Jan 28, 2020 | Matthew C Kapusta64 | CEO, CFO, Managing Director | Sell | 51,872 | $63.90 | $3,314,501.04 | -14.1% | |
| Jan 15, 2020 | Alexander Edward Kuta III81 | Executive VP, Operations | Sale+OE | 4,000 | $68.97 | $275,880.00 | -8.8% | |
| Jan 7, 2020 | Paula Soteropoulos75 | Director | Sell | 3,000 | $72.18 | $216,540.00 | -35.9% | |
| Dec 18, 2019 | Matthew C Kapusta64 | CEO, CFO, Managing Director | Sale+OE | 7,540 | $70.09 | $528,510.46 | -2.0% | |
| Dec 16, 2019 | Alexander Edward Kuta III81 | Executive VP, Operations | Sale+OE | 4,000 | $74.59 | $298,356.04 | -8.8% | |
| Dec 13, 2019 | Paula Soteropoulos75 | Director | Sale+OE | 2,000 | $70.50 | $141,000.00 | -19.3% |